Results 191 to 200 of about 425,993 (391)

Open-Heart Surgery and Viral Risk: Investigation of the Prevalence of HIV, HBV, and HCV in Patients Undergoing Heart Surgery [PDF]

Journal of Mazandaran University of Medical Sciences
Background and purpose: Bloodborne infectious diseases, particularly HBV, HCV, and HIV, are major global health concerns. Patients undergoing open-heart surgery are at a higher risk of infection due to the extensive use of injections and other invasive ...
Lotfollah Davoodi, Farhang Babamahmoodi, Seyed Morteza Taghavi, Kimia Torab Beygi, Sara Ghandi, Maryam Talebi Moghaddam   +5 more
doaj  

MOLECULAR CLONING OF cDNA OF HEPATITIS C VIRUS (HCV) GENOME FROM A HEALTHY CARRIER IN AN ABORIGINAL COMMUNITY IN TAIWAN WITH HIGH PREVALENCE OF HCV INFECTION

, 1991
Wen‐Hsiang Chou, Lisa SHEU, Shu-Fen CHENG, Shu-Hua SHEU, Chih‐Feng Lu, Izumu Saito, Tatsuo Miyamura, Sheng-Yu LIN, Jau‐Shin Wu   +8 more
openalex   +2 more sources

Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.

New England Journal of Medicine, 2014
M. Sulkowski, D. Gardiner, M. Rodríguez-Torres, K. R. Reddy, Tarek Hassanein, Ira M. Jacobson, E. Lawitz, Anna S. Lok, F. Hinestrosa, P. Thuluvath, Howard Schwartz, David R. Nelson, Gregory T. Everson, T. Eley, M. Wind-Rotolo, Shu‐Pang Huang, Min Gao, D. Hernandez, F. Mcphee, D. Sherman, R. Hindes, W. Symonds, Claudio Pasquinelli, D. Grasela   +23 more
semanticscholar   +1 more source

Dynamics of Cardiometabolic Risk Factors Are Linked to the Risk of Hypertension and Diabetes in MASLD

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigates the impact of cardiometabolic risk factors (CMRF) on the prevalence and incidence of hypertension (HTN) and diabetes mellitus (DM) in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and nonsteatotic liver disease (non‐SLD), using both cross‐sectional and longitudinal data. A total of 32,
Chin‐I Shih, Ming‐Lun Yeh, Yi‐Hung Lin, Ping‐Tsung Shih, Kuan‐Ta Wu, Meng‐Hsuan Hsieh, Jeng‐Fu Yang, Yi‐Yu Chen, Po‐Cheng Liang, Yu‐Ju Wei, Pei‐Chien Tsai, Ya‐Yun Cheng, Ming‐Yen Hsieh, Chih‐Wen Wang, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Chi‐Kung Ho, Wan‐Long Chuang, Vincent Wai‐Sun Wong, Wei‐Ting Chang, Ming‐Lung Yu   +21 more
wiley   +1 more source

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin, Ming‐Lun Yeh, Po‐Cheng Liang, Shinn‐Cherng Chen, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang   +8 more
wiley   +1 more source

Detection of HCV associated antigen in human chronic hepatitis C liver.

, 1992
Mitsuhiko Moriyama, Fumihiko Komine, K Fujibayashi, Junko MORIYAMA, Takashi Motohashi, Kazutomo Suzuki, Shuichi Amaki, Naohide Tanaka, Hitoshi Okubo, Hideo Ishizuka, Yasuyuki Arakawa, Yutaka Matsuo, Nakanobu Hayashi, K Suzuki, Toshikazu Uchida, Toshio Shikata, Yohko K. Shimizu, Masaharu Hiraga, Akira Nishizono, Tetsuo KAWAHARA, Kyosuke Mizuno   +20 more
openalex   +2 more sources

Mapping protein–protein interactions by mass spectrometry

Mass Spectrometry Reviews, EarlyView.
Abstract Protein–protein interactions (PPIs) are essential for numerous biological activities, including signal transduction, transcription control, and metabolism. They play a pivotal role in the organization and function of the proteome, and their perturbation is associated with various diseases, such as cancer, neurodegeneration, and infectious ...
Xiaonan Liu, Lawrence Abad, Lopamudra Chatterjee, Ileana M. Cristea, Markku Varjosalo   +4 more
wiley   +1 more source

Disease Progression Mathematical Modeling With a Case Study on Hepatitis B Virus Infection

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 420-434, March 2025.
ABSTRACT Chronic Hepatitis B presents a significant health and socioeconomic burden. The risk of hepatocellular carcinoma remains elevated although treatments are available. Achieving an optimal treatment regimen necessitates a deep comprehension of the dynamic relationship between the virus and its host across disease states.
Clémence Boivin‐Champeaux, Nieves Velez de Mendizabal, Aksana Jones, Scott Balsitis, Stephan Schmidt, Justin S. Feigelman, Francine Johansson Azeredo   +6 more
wiley   +1 more source

Interferon therapy for HCV-RNA positive chronic hepatitis.

, 1993
Yasuji Arase, Kazuaki Chayama, Akihito Tsubota, Isamu KOIDA, Satoshi Saitô, Kenji Ikeda, Hiromitsu Kumada, Toyomi MATSUMOTO, Yoko Sakai, Mariko Kobayashi   +9 more
openalex   +2 more sources

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

New England Journal of Medicine, 2015
G. Foster, N. Afdhal, S. Roberts, N. Bräu, E. Gane, S. Pianko, E. Lawitz, A. Thompson, M. Shiffman, C. Cooper, W. Towner, B. Conway, P. Ruane, M. Bourlière, T. Asselah, T. Berg, S. Zeuzem, W. Rosenberg, K. Agarwal, C. Stedman, H. Mo, H. Dvory‐Sobol, Lingling Han, Jing Wang, J. McNally, A. Osinusi, D. Brainard, J. Mchutchison, F. Mazzotta, T. Tran, S. Gordon, K. Patel, N. Reau, A. Mangia, M. Sulkowski   +34 more
semanticscholar   +1 more source